BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 31042258)

  • 1. Risk of Melanoma Recurrence After Diagnosis of a High-Risk Primary Tumor.
    von Schuckmann LA; Hughes MCB; Ghiasvand R; Malt M; van der Pols JC; Beesley VL; Khosrotehrani K; Smithers BM; Green AC
    JAMA Dermatol; 2019 Jun; 155(6):688-693. PubMed ID: 31042258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Greater Tumor Thickness, Ulceration, and Positive Sentinel Lymph Node Are Associated With Worse Prognosis in Patients With Conjunctival Melanoma: Implications for Future AJCC Classifications.
    Esmaeli B; Rubin ML; Xu S; Goepfert RP; Curry JL; Prieto VG; Ning J; Tetzlaff MT
    Am J Surg Pathol; 2019 Dec; 43(12):1701-1710. PubMed ID: 31425167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Melanoma Nodal Positivity and Biopsy Rates Before and After Implementation of the 7th Edition of the AJCC Cancer Staging Manual.
    Isom C; Wheless L; Hooks MA; Kauffmann RM
    JAMA Dermatol; 2019 May; 155(5):572-577. PubMed ID: 30840034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
    Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
    Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-institution experience in the management of patients with clinical stage I and II cutaneous melanoma: results of sentinel lymph node biopsy in 240 cases.
    Rex J; Paradelo C; Mangas C; Hilari JM; Fernández-Figueras MT; Fraile M; Alastrué A; Ferrándiz C
    Dermatol Surg; 2005 Nov; 31(11 Pt 1):1385-93. PubMed ID: 16416605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodular Histologic Subtype and Ulceration are Tumor Factors Associated with High Risk of Recurrence in Sentinel Node-Negative Melanoma Patients.
    Faut M; Wevers KP; van Ginkel RJ; Diercks GF; Hoekstra HJ; Kruijff S; Been LB; van Leeuwen BL
    Ann Surg Oncol; 2017 Jan; 24(1):142-149. PubMed ID: 27646020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes.
    Zogakis TG; Essner R; Wang HJ; Foshag LJ; Morton DL
    Ann Surg Oncol; 2007 May; 14(5):1604-11. PubMed ID: 17333418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
    Fairbairn NG; Orfaniotis G; Butterworth M
    J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional nodal metastasis and 5-year survival in patients with thin melanoma in Queensland: a population-based study.
    Theile H; Moore J; Dunn N; Cossio D; Forristal CE; Green AC; Smithers BM
    ANZ J Surg; 2020 Apr; 90(4):503-507. PubMed ID: 32162780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of a Model for Predicting the Risk of Sentinel Lymph Node Metastasis in Patients With Cutaneous Melanoma.
    Marchetti MA; Dusza SW; Bartlett EK
    JAMA Dermatol; 2022 Jun; 158(6):680-683. PubMed ID: 35475908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma.
    Hieken TJ; Grotz TE; Comfere NI; Inselman JW; Habermann EB
    Melanoma Res; 2015 Apr; 25(2):157-63. PubMed ID: 25647736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel node biopsy status is strongly predictive of survival in cutaneous melanoma: Extended follow-up of Oxford patients from 1998 to 2014.
    Thomson DR; Rughani MG; Kuo R; Cassell OCS
    J Plast Reconstr Aesthet Surg; 2017 Oct; 70(10):1397-1403. PubMed ID: 28625757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favourable prognostic role of regression of primary melanoma in AJCC stage I-II patients.
    Ribero S; Osella-Abate S; Sanlorenzo M; Savoia P; Astrua C; Cavaliere G; Tomasini C; Senetta R; Macripò G; Bernengo MG; Quaglino P
    Br J Dermatol; 2013 Dec; 169(6):1240-5. PubMed ID: 23952011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients.
    Statius Muller MG; van Leeuwen PA; van Diest PJ; Pijpers R; Nijveldt RJ; Vuylsteke RJ; Meijer S
    World J Surg; 2002 Dec; 26(12):1405-11. PubMed ID: 12297910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved stratification of pT1 melanoma according to the 8th American Joint Committee on Cancer staging edition criteria: A Dutch population-based study.
    Verver D; Louwman WJ; Koljenović S; Verhoef C; Grünhagen DJ; van Akkooi ACJ
    Eur J Cancer; 2018 Mar; 92():100-107. PubMed ID: 29217356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and patterns of recurrence after sentinel lymph node biopsy for thin melanoma.
    Kim D; Chu S; Khan AU; Compres EV; Zhang H; Gerami P; Wayne JD
    Arch Dermatol Res; 2022 Apr; 314(3):285-292. PubMed ID: 33884478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
    Berk DR; Johnson DL; Uzieblo A; Kiernan M; Swetter SM
    Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive Breast Cancer.
    Carleton N; Zou J; Fang Y; Koscumb SE; Shah OS; Chen F; Beriwal S; Diego EJ; Brufsky AM; Oesterreich S; Shapiro SD; Ferris R; Emens LA; Tseng G; Marroquin OC; Lee AV; McAuliffe PF
    JAMA Netw Open; 2021 Apr; 4(4):e216322. PubMed ID: 33856473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.